Study of NovaDerm in burn patients

Trial Profile

Study of NovaDerm in burn patients

Planning
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2017

At a glance

  • Drugs Human skin replacement-Regenicin (Primary)
  • Indications Burns
  • Focus Adverse reactions
  • Sponsors Regenicin
  • Most Recent Events

    • 18 Jan 2017 According to a Regenicin media release, companay is planning to Schedule 10 subjects at two burn centers. Grafting will be performed on subjects in this trial in 2017.
    • 01 Nov 2016 According to a Regenicin Inc. media release, the company has completed pre-IND meeting with the FDA Office of Cellular, Tissue, and Gene Therapies (OCTGT) in the Center for Biologics Evaluation and Research (CBER) on October 27th, 2016 regarding NovaDerm.
    • 12 Oct 2016 According to a Regenicin Inc., media release the company has scheduled a Pre-IND meeting with FDA Office on 27th Oct 2016 regarding the development of NovaDerm.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top